Conestoga has been busy in the New Year, with investments across the biotechnology sector, all reported today. Here at Small Cap Exclusive, of course, we’re keeping up with things, however busy they may be. Here’s what the latest filing has revealed.
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Mesa Laboratories Inc. (NASDAQ:MLAB) reported that Conestoga Capital Advisors, Llc. has picked up 218,886 of common stock as of 2017-01-05.
The acquisition brings the aggregate amount owned by Conestoga Capital Advisors, Llc. to a total of 218,886 representing a 5.95% stake in the company.
For those not familiar with the company, Mesa Laboratories, Inc. is focused primarily on quality control products and services. The Company operates through four segments: Instruments, Continuous Monitoring, Biological Indicators and Cold Chain. The Instruments Division designs, manufactures and markets quality control instruments and disposable products. Its Biological Indicators Division provides testing services, along with the manufacturing and marketing of biological indicators and distribution of chemical indicators used to assess the effectiveness of sterilization processes. Its Continuous Monitoring Division designs, develops and markets systems, which are used to monitor various environmental parameters.
A glance at Mesa Laboratories Inc. (NASDAQ:MLAB)’s key stats reveals a current market capitalization of 469.13 million based on 3.68 million shares outstanding and a price at last close of $125.62 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2015-09-22, Campbell picked up 150 at a purchase price of $109.54. This brings their total holding to 78,848 as of the date of the filing.
On the sell side, the most recent transaction saw Dwyer unload 1,000 shares at a sale price of $134.00. This brings their total holding to 89,671.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Mesa Laboratories Inc. (NASDAQ:MLAB) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
